Suchergebnisse - "Vékony, Bálint"

PubPharm (7)

1

MicroRNA-Mediated Suppression of Glial Cell Line-Derived Neurotrophic Factor Expression Is Modulated by a Schizophrenia-Associated Non-Coding Polymorphism

enthalten in: International journal of molecular sciences | 2024

von Keszler, G. | Vékony, B. | Elek, Z. | +6

2

Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients-a systematic review and meta-analysis

enthalten in: Prostate cancer and prostatic diseases | 2023

von Fazekas, T. | Széles, �. | Teutsch, B. | +12

3

Poly (ADP-ribose) Polymerase Inhibitors Have Comparable Efficacy with Platinum Chemotherapy in Patients with BRCA-positive Metastatic Castration-resistant Prostate Cancer. A Systematic Review and Meta-analysis

enthalten in: European urology oncology | 2023

von Fazekas, T. | Széles, �. | Teutsch, B. | +8

4

The genetic background of primary aldosteronism

enthalten in: Orvosi hetilap | 2023

von Vékony, B. | Igaz, P.

5

Liquid biopsy for the assessment of adrenal cancer heterogeneity : where do we stand?

enthalten in: Endocrine | 2022

von Perge, P. | Nyirő, G. | Vékony, B. | +1

CommentIn: Endocrine. 2022 Sep;77(3):409-410. - PMID 35867326

6

Liquid biopsy for the assessment of adrenal cancer heterogeneity: where do we stand?

enthalten in: EJE | 2022

von Perge, P. | Nyirő, G. | Vékony, B. | +1

7

Liquid biopsy for the assessment of adrenal cancer heterogeneity: where do we stand?

enthalten in: Endocrine | 2022

von Perge, P. | Nyirő, G. | Vékony, B. | +1

1
[1]